Physician profile
Misti Morgan
NPI 1073069589
$1,975.28
in general payments reported to CMS, 2019-2025
17 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $243 · 2022: $374 · 2023: $551 · 2024: $437 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,269 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,268.83 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $474.27 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $363.50 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $243.89 | 2023-2025 | Veozah |
| Pfizer INC. | $186.85 | 2021-2024 | |
| Evofem Biosciences, INC. | $157.57 | 2021-2024 | Phexxi |
| Myovant Sciences INC. | $107.40 | 2022 | |
| Organon LLC | $81.03 | 2023-2025 | Nexplanon |
| Lupin INC. | $80.55 | 2021 | |
| Exeltis, USA INC. | $57.91 | 2024 | Slynd |
| Avion Pharmaceuticals | $40.47 | 2021-2023 | Balcoltra |
| Millicent US INC | $39.52 | 2025 | Intrarosa |
| Sage Therapeutics, LLC | $33.67 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $32.89 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $21.53 | 2025 | Auvelity |
| Amgen INC. | $19.06 | 2023 | Prolia, Evenity |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $18.67 | 2022 | |
| Supernus Pharmaceuticals, INC. | $16.50 | 2025 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Misti Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.